PHARMAGREEN BIOTECH INC. Financing Cash Flow
PHARMAGREEN BIOTECH INC. reported Financing Cash Flow of $83.96 thousand for the 9-month period ending 2023-06-30, per its 10-Q filed 2023-08-14.
Discontinued › Cash Flow › Financing Activities
us-gaap:NetCashProvidedByUsedInFinancingActivities · last filed 2023-08-14
- PHARMAGREEN BIOTECH INC. net cash provided by (used in) financing activities for the quarter ending 2023-06-30 was $17.69K, a 84.36% decline year-over-year.
- PHARMAGREEN BIOTECH INC. net cash provided by (used in) financing activities for the quarter ending 2023-03-31 was $18.84K, a 70.84% decline year-over-year.
- PHARMAGREEN BIOTECH INC. net cash provided by (used in) financing activities for the quarter ending 2022-12-31 was $47.43K, a 65.11% decline year-over-year.
- PHARMAGREEN BIOTECH INC. net cash provided by (used in) financing activities for the quarter ending 2022-09-30 was $0.00, a 100.00% decline year-over-year.
- PHARMAGREEN BIOTECH INC. net cash provided by (used in) financing activities for fiscal 2022 was $313.71K, a 21.83% increase from fiscal 2021.
- PHARMAGREEN BIOTECH INC. net cash provided by (used in) financing activities for fiscal 2021 was $257.50K, a 54.23% decline from fiscal 2020.
- PHARMAGREEN BIOTECH INC. net cash provided by (used in) financing activities for fiscal 2020 was $562.62K, a 29.99% increase from fiscal 2019.
- PHARMAGREEN BIOTECH INC. net cash provided by (used in) financing activities for fiscal 2019 was $432.83K, a 61.45% decline from fiscal 2018.
| Period end | Net Cash Provided by (Used in) Financing Activities 3 month | Net Cash Provided by (Used in) Financing Activities 6 month | Net Cash Provided by (Used in) Financing Activities 9 month | Net Cash Provided by (Used in) Financing Activities 12 month |
|---|---|---|---|---|
| 2023-06-30 | $17.69K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-08-14 | $36.53K derived: sum of 2 quarters · filed 2023-08-14 | $83.96K 10-Q · filed 2023-08-14 | $83.96K derived: sum of 4 quarters · filed 2023-08-14 |
| 2023-03-31 | $18.84K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-05-19 | $66.27K 10-Q · filed 2023-05-19 | $66.27K derived: sum of 3 quarters · filed 2023-05-19 | $179.41K derived: sum of 4 quarters · filed 2023-08-14 |
| 2022-12-31 | $47.43K 10-Q · filed 2023-02-14 | $47.43K derived: sum of 2 quarters · filed 2023-02-14 | $160.57K derived: sum of 3 quarters · filed 2023-08-14 | $225.18K derived: sum of 4 quarters · filed 2023-08-14 |
| 2022-09-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-01-17 | $113.14K derived: sum of 2 quarters · filed 2023-08-14 | $177.75K derived: sum of 3 quarters · filed 2023-08-14 | $313.71K 10-K · filed 2023-01-17 |
| 2022-06-30 | $113.14K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-08-14 | $177.75K derived: sum of 2 quarters · filed 2023-08-14 | $313.71K 10-Q · filed 2023-08-14 | $350.82K derived: sum of 4 quarters · filed 2023-08-14 |
| 2022-03-31 | $64.61K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-05-19 | $200.57K 10-Q · filed 2023-05-19 | $237.68K derived: sum of 3 quarters · filed 2023-05-19 | $301.18K derived: sum of 4 quarters · filed 2023-05-19 |
| 2021-12-31 | $135.96K 10-Q · filed 2023-02-14 | $173.08K derived: sum of 2 quarters · filed 2023-02-14 | $236.58K derived: sum of 3 quarters · filed 2023-02-14 | $332.80K derived: sum of 4 quarters · filed 2023-02-14 |
| 2021-09-30 | $37.12K derived: 10-K 12 month − 10-Q 9 month · filed 2023-01-17 | $100.62K derived: sum of 2 quarters · filed 2023-01-17 | $196.84K derived: sum of 3 quarters · filed 2023-01-17 | $257.50K 10-K · filed 2023-01-17 |
| 2021-06-30 | $63.50K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-08-17 | $159.72K derived: sum of 2 quarters · filed 2022-08-17 | $220.38K 10-Q · filed 2022-08-17 | $252.37K derived: sum of 4 quarters · filed 2022-08-17 |
| 2021-03-31 | $96.22K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-05-16 | $156.88K 10-Q · filed 2022-05-16 | $188.87K derived: sum of 3 quarters · filed 2022-05-16 | $274.70K derived: sum of 4 quarters · filed 2022-05-16 |
| 2020-12-31 | $60.66K 10-Q · filed 2022-02-22 | $92.64K derived: sum of 2 quarters · filed 2022-02-22 | $178.47K derived: sum of 3 quarters · filed 2022-02-22 | $555.17K derived: sum of 4 quarters · filed 2022-02-22 |
| 2020-09-30 | $31.98K derived: 10-K 12 month − 10-Q 9 month · filed 2021-12-29 | $117.82K derived: sum of 2 quarters · filed 2021-12-29 | $494.51K derived: sum of 3 quarters · filed 2021-12-29 | $562.62K 10-K · filed 2021-12-29 |
| 2020-06-30 | $85.83K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-08-18 | $462.53K derived: sum of 2 quarters · filed 2021-08-18 | $530.64K 10-Q · filed 2021-08-18 | $688.71K derived: sum of 4 quarters · filed 2021-08-18 |
| 2020-03-31 | $376.70K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-05-24 | $444.80K 10-Q · filed 2021-05-24 | $602.88K derived: sum of 3 quarters · filed 2021-05-24 | $707.60K derived: sum of 4 quarters · filed 2021-05-24 |
| 2019-12-31 | $68.11K 10-Q · filed 2020-02-18 | $226.18K derived: sum of 2 quarters · filed 2021-01-08 | $330.90K derived: sum of 3 quarters · filed 2021-01-08 | $440.14K derived: sum of 4 quarters · filed 2021-01-08 |
| 2019-09-30 | $158.08K derived: 10-K 12 month − 10-Q 9 month · filed 2021-01-08 | $262.80K derived: sum of 2 quarters · filed 2021-01-08 | $372.03K derived: sum of 3 quarters · filed 2021-01-08 | $432.83K 10-K · filed 2021-01-08 |
| 2019-06-30 | $104.72K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-08-19 | $213.95K derived: sum of 2 quarters · filed 2020-08-19 | $274.75K 10-Q · filed 2020-08-19 | $709.09K derived: sum of 4 quarters · filed 2020-08-19 |
| 2019-03-31 | $109.23K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-05-19 | $170.03K 10-Q · filed 2020-05-19 | $604.37K derived: sum of 3 quarters · filed 2020-05-19 | |
| 2018-12-31 | $60.80K 10-Q · filed 2020-02-18 | $495.13K derived: sum of 2 quarters · filed 2020-02-18 | ||
| 2018-09-30 | $434.33K derived: 10-K 12 month − 10-Q 9 month · filed 2019-12-30 | $1.12M 10-K · filed 2019-12-30 | ||
| 2018-06-30 | $688.30K 10-Q · filed 2019-08-19 |